---
title: "To investigate the safety and efficacy of a novel investigational compound against neurological diseases such as Parkinson's disease in healthy men and women and patients with Parkinson's disease."
euct_id: 2025-521357-17-00
phase: Phase 1
status: Recruiting
sponsor: Teitur Trophics ApS
canonical_url: "https://parkinsonspathways.com/trials/eu/2025-521357-17-00"
eu_clinical_trials_register: "https://euclinicaltrials.eu/ctis-public/view/2025-521357-17-00"
ctis_last_updated: "2026-03-12T02:38:49.180917741"
source: EU Clinical Trials Information System (CTIS)
---
# To investigate the safety and efficacy of a novel investigational compound against neurological diseases such as Parkinson's disease in healthy men and women and patients with Parkinson's disease.

**EU CT Number:** [2025-521357-17-00](https://euclinicaltrials.eu/ctis-public/view/2025-521357-17-00)

## Key Facts

- **Phase:** Phase 1
- **Status:** Recruiting
- **Sponsor:** Teitur Trophics ApS
- **Start Date:** 2025-06-09
- **Completion Date:** 2026-06-09
- **Conditions:** Parkinson's disease

## Member States

Trial is authorized in 1 member state: Netherlands.

## Sites (1)

- Centre for Human Drug Research, Leiden, Netherlands

## Eligibility (CTIS)

- **Minimum age:** 18 Years
- **Sex:** ALL

```
Condition: Parkinson's disease
Age groups: elderly 65+, adults 18-64
Sex: male, female
```

---

*Canonical: https://parkinsonspathways.com/trials/eu/2025-521357-17-00*  
*HTML version: https://parkinsonspathways.com/trials/eu/2025-521357-17-00*  
*Source data: https://euclinicaltrials.eu/ctis-public/view/2025-521357-17-00*